A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

By Coleman R.E.   Houston S.   Purohit O.P.   Rubens R.D.   Kandra A.   Ford J.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 820-824

Elsevier

Access to resources Recommend Favorite

Pamidronate Infusions as Single-agent Therapy for Bone Metastases: A Phase II Trial in Patients with Breast Cancer

By Tyrrell C.T.   Bruning P.F.   May-Levin F.   Rose C.   Mauriac L.   Soukop M.   Ford J.M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1976-1980

Elsevier

Access to resources Recommend Favorite

Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

By Kristensen Bent   Ejlertsen Bent   Mouridsen Henning   Jensen Maj-Britt   Andersen Jørn   Bjerregaard Brita   Cold Søren   Edlund Per   Ewertz Marianne   Kamby Claus   Lindman Henrik   Nordenskjold Bo   Bergh Jonas  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Acute Effects of Pamidronate Administration on Serum Levels of Interleukin-6 in Advanced Solid Tumour Patients with Bone Metastases and their Possible Implications in the Immunotherapy of Cancer with Interleukin-2

By Lissoni P.   Cazzaniga M.   Barni S.   Perego M.S.   Brivio F.   Fumagalli L.   Tancini G.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 304-306

Elsevier

Access to resources Recommend Favorite

Acquisition of metastatic tissue from patients with bone metastases from breast cancer

By Hilton J.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 761-765

Springer Publishing Company

Access to resources Recommend Favorite